谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Efficacy and safety of oral decitabine/cedazuridine (astx727) in the cmml subpopulation from phase 2 and ascertain phase 3 studies

M. Savona,J. Mccloskey,E. Griffiths,K. Yee,A. Zeidan,A. Al-Kali,H. J. Deeg,P. Patel,M. Sabloff,M. -M. Keating,N. Zhu,N. Gabrail,S. Fazal,J. Maly,O. Odenike,H. Kantarjian,A. Dezern,C. O'Connell,G. Roboz,L. Busque,R. Buckstein,H. Amin, J. Randhawa,B. Leber,K. -H. Dao, Y. Sano,B. Mirakhur,H. Keer,G. Garcia-Manero

LEUKEMIA RESEARCH（2023）

引用 0|浏览20
暂无评分
关键词
MDS, oral decitabine/cedazuridine, oral, hypomethylating agent, CMML, phase II, phase III
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要